Literature DB >> 23739696

Cutaneous blastomycosis: a clue to a systemic disease.

Alex G Ortega-Loayza1, Tuyet Nguyen.   

Abstract

A 55-year-old male presented with back pain and slightly tender annular plaques with central ulceration on his face. A skin biopsy revealed scattered yeast with broad based buds. A CT scan of the abdomen revealed a pathologic T12 fracture. Tissue obtained from the spine confirmed budding yeasts. The patient was diagnosed with disseminated blastomycosis. The patient was treated with amphotericin and itraconazole and completely recovered.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23739696      PMCID: PMC3750900          DOI: 10.1590/S0365-05962013000200022

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


A 55 year-old white male from Virginia, USA presented to the emergency room with right flank and back pain for approximately three weeks and a facial eruption without other symptoms. On physical examination, the patient was found to have verrucous plaques with raised borders and eroded centers on the left paranasal labial fold and right jawline (Figures 1 and 2). There was no pain to palpation on his abdomen, flank or spine. There were no neurological deficits. HIV test was negative. The patient's CT of the abdomen and pelvis revealed a pathologic compression fracture at the T12 level (Figure 3). The skin biopsy of the facial lesion showed pseudoepitheliomatous hyperplasia with an inflammatory infiltrate and the presence of broad-based budding fungal organism suggestive of Blastomyces dermatitidis (Figure 4). The fine needle aspiration and bone biopsy as well as the fungal culture confirmed the diagnosis. Subsequent chest imaging showed diffuse nodular opacities in all lung lobes. The final diagnosis was disseminated blastomycosis with bone involvement. The patient was initially started on itraconazole, but due to symptoms of spinal cord compression, was ultimately given amphotericin B. The patient completely improved with this treatment and showed resolution of skin lesions.
FIGURE 1

Patient with a couple of verrucous and eroded plaques on the face

FIGURE 2

A close up of the lesions on the face

FIGURE 3

The arrow indicates the compression fracture at the T12 level

FIGURE 4

H&E and PAS staining of the skin biopsy showing mixed inflammatory infiltrate and fungal organisms. (Courtesy Dr Nooshin K Brinster, MD,Virginia Commonwealth University)

Patient with a couple of verrucous and eroded plaques on the face A close up of the lesions on the face The arrow indicates the compression fracture at the T12 level H&E and PAS staining of the skin biopsy showing mixed inflammatory infiltrate and fungal organisms. (Courtesy Dr Nooshin K Brinster, MD,Virginia Commonwealth University) Blastomyces dermatitidis is endemic to the Mississippi and Ohio river basins, encompassing many Eastern and Southern states in United States.[1-4]It has an annual incidence of 12 - 40 cases per 100 000 within endemic regions.[1] It also affects patients in Africa and Canada.[1,3,4] Blastomyces dermatidis affects primarily the lungs, skin, and other viscera. The most important form is primary pulmonary blastomycosis. Most cases are asymptomatic; the rest displays mild to severe respiratory findings similar to tuberculosis or other systemic mycosis.[3] Skin involvement has been reported in 40-80% of the cases. The cutaneous manifestations of blastomycosis come in two forms, verrucous and ulcerative.[1,2] Five categories of blastomycosis have been defined: primary pulmonary disease, single organ system disease, generalized multiorgan disease, chronic cutaneous disease and inoculation blastomycosis. The greatest challenge in making the diagnosis of blastomycosis is difficult recognition of the condition.[1] Without treatment, the prognosis is grave when infection spreads beyond the lung; the case fatality rate for disseminated blastomycosis was 78% prior to the availability of specific fungal therapy.[1] The disseminated form of blastomycosis is not typically diagnosed until late in its course, consequently affecting morbidity.[2] Early diagnosis and therapy can lead to resolution and prevent clinical relapse. No clinical or radiographic abnormalities are absolutely diagnostic of blastomycosis, therefore visualization of the characteristic yeast forms or growth of the fungus in culture is necessary for diagnosis.[1] Cutaneous alternariosis can also mimick blastomycosis, which must be differentiated by culture.[5] The differential diagnoses of cutaneous blastomycosis include dimorphic fungi, basal cell carcinoma, squamous cell carcinoma, giant keratoacanthoma, scrofuloderma, lupus vulgaris, atypical mycobacterium, nocardiosis, syphilis, bromoderma, iododerma, leishmaniasis, granuloma inguinale, lymphoma and pyoderma gangrenosum.[1-3] This case highlights the clinical manifestations of disseminated blastomycosis and stresses the importance of maintaining a high index of suspicion in an endemic region. Moreover, imported cases have been reported in the literature.[5] It is critical for the diagnostician to recognize the clinical pattern of lesions that can be restricted to the skin and mucous surfaces or even present as visceral dissemination. Dermatologists from all over the world should be prepared to recognize and diagnose tropical mycoses.[6]
  6 in total

1.  Cutaneous alternariosis microscopically mimicking blastomycosis.

Authors:  Gregory W Osmond; Robert W Walters; Puja K Puri
Journal:  J Cutan Pathol       Date:  2011-07-14       Impact factor: 1.587

Review 2.  Endemic systemic mycoses: coccidioidomycosis, histoplasmosis, paracoccidioidomycosis and blastomycosis.

Authors:  Alexandro Bonifaz; Denisse Vázquez-González; Ana María Perusquía-Ortiz
Journal:  J Dtsch Dermatol Ges       Date:  2011-07-04       Impact factor: 5.584

3.  [Blastomycosis: report of an imported case in Mexico, with only cutaneous lesions].

Authors:  Adriana Rodríguez-Mena; Jorge Mayorga; Guillermo Solís-Ledesma; José Barba-Gómez
Journal:  Rev Iberoam Micol       Date:  2010-06-12       Impact factor: 1.044

Review 4.  Clinical and laboratory update on blastomycosis.

Authors:  Michael Saccente; Gail L Woods
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 5.  Tropical dermatology: fungal tropical diseases.

Authors:  Omar Lupi; Stephen K Tyring; Michael R McGinnis
Journal:  J Am Acad Dermatol       Date:  2005-12       Impact factor: 11.527

6.  Cutaneous blastomycosis: a diagnostic challenge.

Authors:  Ashley R Mason; Gil Y Cortes; Joel Cook; John C Maize; Bruce H Thiers
Journal:  Int J Dermatol       Date:  2008-08       Impact factor: 2.736

  6 in total
  3 in total

Review 1.  Challenges in diagnosis of limited granulomatosis with polyangiitis.

Authors:  Olena Zimba; Bohdana Doskaliuk; Roman Yatsyshyn; Mykola Bahrii; Marta Hrytsevych
Journal:  Rheumatol Int       Date:  2021-04-20       Impact factor: 2.631

2.  Blastomycosis and Pregnancy: An Unusual Postpartum Disease Course.

Authors:  David Surprenant; Monika Kaniszewska; Kelli Hutchens; Christine Go; Paul O'Keefe; James Swan; Rebecca Tung
Journal:  Case Rep Dermatol       Date:  2015-05-28

3.  Amphotericin-B in Dermatology.

Authors:  Akash Agarwal; Bikash R Kar
Journal:  Indian Dermatol Online J       Date:  2022-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.